Compare MaxLinear Inc. Common Stock (MXL) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MaxLinear Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? MaxLinear Inc. Common Stock trades at $96.37 (market cap $9.74B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: MaxLinear Inc. Common Stock is far larger — about 2.5× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is more actively traded (3,432,928 versus 2,786,741). Which is the better fit depends on your goals — on Pluang, investors hold MaxLinear Inc. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| MXL | RLAY | |
|---|---|---|
Market Cap | $9.74B | $3.94B |
Volume | 2,786,741 | 3,432,928 |
Sector | Technology | Health |
52-Week High | $128.03 | $20.75 |
52-Week Low | $13.05 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.83B | $3.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MaxLinear Inc. Common Stock
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
